As a result of a capa investigation, past legal communication was found that was identified as requiring a medwatch report.The company has decided to submit this mdr for information purposes in an abundance of caution and to ensure full compliance with 21 cfr part 803.Based upon the intended use of the product, if a positive result is obtained, the physician is advised to repeat the test for confirmation, and in general the results of the screening test are to be taken into consideration with the patient's epidemiological history, current medical status and results of other diagnostic evaluations.The alleged problems reported are the outcome of diagnosis, and subsequent treatment of the pt using (b)(6).Cellestis filed notification of their voluntary recall through the regional fda district recall office on 10/16/2012.Closure of the recall by the fda was received 4/25/2013.
|